A number of previous studies have demonstrated correlations between levels of circulating SPP1 and/or increased SPP1 expression on tumor cells and poor prognosis in various cancers, including non-small cell lung cancer (NSCLC) ([41,42,43,44,45,46,47], summarized in Table S1). The gene discussed is SPP1; the disease is neoplasm.